Efficacy of Early Continuous Infusion of HSS on the Neurological Outcome at 6 Months in TBI Patients. | MicrobiomeTrials← Back to trialsNCT07319208
Efficacy of Early Continuous Infusion of HSS on the Neurological Outcome at 6 Months in TBI Patients.
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-04-21Est. Completion: 2028-06-01
Enrollment target: 760 participants Locations- CHU d'Angers, Angers, France
- CHU de Brest, Brest, France
- CHU Caen Normandie, Caen, France
- CHU de Clermont- Ferrand, Clermont-Ferrand, France
- Hôpital BEAUJON APHP, Clichy, France
- CHU Henri Mondor APHP, Créteil, France
- CH de Annecy Genevois, Épagny, France
- CHU de Grenoble, Grenoble, France
- CHU de Lille, Lille, France
- HCL, Lyon, France
- AP-HM, Marseille, France
- CHU de Nancy, Nancy, France
- CHU de Nantes, Nantes, France
- CHU de Nice, Nice, France
- CHU Lariboisière, AP-HP, Paris, France
- GHU Paris Cité, Paris, France
- CHU de Poitiers, Poitiers, France
- CHU de Rennes, Rennes, France
- CHU de Rouen, Rouen, France
- CHU de St- Etienne, Saint-Etienne, France
- CHU de Strasbourg, Strasbourg, France
- CHU de Toulouse, Toulouse, France
Other microbiome trials you might be interested in
Traumatic Brain Injury
The goal of this clinical trial is to evaluate the effectiveness of a home-based cognitive-motor telerehabilitation prog…
Milan, ItalyEst. completion Mar 31, 2029
Traumatic Brain Injury
A moderate traumatic brain injury (TBI) occurring in early or middle adulthood might have long-lasting effects on the br…
Gainesville, United StatesCompleted Jun 30, 2026
CHRU de Tours, Tours, France